Eli Lilly to expand pain pipeline with $1bn SiteOne buyout
The deal tees up a pain treatment market rivalry with Vertex Pharmaceuticals as the industry starts to move away from opioids.
The deal tees up a pain treatment market rivalry with Vertex Pharmaceuticals as the industry starts to move away from opioids.
What's Your Reaction?
